Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 38 days early.
- 202510/07/2026
- 202404/07/2025
- 202326/06/2024
- 202215/06/2023
- 202131/05/2022
- 202021/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and (20.4)
National Health Fund (NFZ) contracts
Bober-Pharm has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Provision of medical devices | świętokrzyskie | 1 | USD 0.00 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Wojciech Boberage 43 | 20 | $5,402.49 | 33.3333% |
Stanisław Adam Boberage 77 | 20 | $5,402.49 | 33.3333% |
Katarzyna Małgorzata Bober Matuszczykage 50 | 20 | $5,402.49 | 33.3333% |
Piotr Wojciech Bober and Stanisław Adam Bober hold a combined 66.7% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-11-30.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $78,374$78,374 |
Buildings and premises | $14,611$14,611 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $104.7K$104,713 | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-KielceS.A. | – | farmacol.com.pl |
FAQ
Last updated: 2026-07-15